Anderson Kenneth Carl bought CCCC
January 2, 2026 · Form 4 insider transaction
Anderson Kenneth Carl bought 5,958 shares of C4 Therapeutics, Inc. at $1.93 per share, a transaction worth $11.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,958
Price
$1.93
Total value
$11.5K
InsiderAnderson Kenneth Carl
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after146,532
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.; The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026.